In a letter to the chief secretaries, the National Pharmaceutical
Pricing Authority (NPPA) has asked them to ensure that there is no
violation to the provisions of the Drug Pricing Control Order (DPCO)
with regard to compliance of selling price.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/nppa-tells-chief-secys-to-keep-tabs-on-api-availability/articleshow/74292731.cms
Monday, February 24, 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment